These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16473908)

  • 21. (19)F nuclear magnetic resonance and crystallographic studies of 5-fluorotryptophan-labeled anthrax protective antigen and effects of the receptor on stability.
    Chadegani F; Lovell S; Mullangi V; Miyagi M; Battaile KP; Bann JG
    Biochemistry; 2014 Feb; 53(4):690-701. PubMed ID: 24387629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A FRET-based high throughput screening assay to identify inhibitors of anthrax protective antigen binding to capillary morphogenesis gene 2 protein.
    Rogers MS; Cryan LM; Habeshian KA; Bazinet L; Caldwell TP; Ackroyd PC; Christensen KA
    PLoS One; 2012; 7(6):e39911. PubMed ID: 22768167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Divalent metal ion coordination by residue T118 of anthrax toxin receptor 2 is not essential for protective antigen binding.
    Scobie HM; Young JA
    PLoS One; 2006 Dec; 1(1):e99. PubMed ID: 17183731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changing the receptor specificity of anthrax toxin.
    Mechaly A; McCluskey AJ; Collier RJ
    mBio; 2012; 3(3):. PubMed ID: 22550037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The inhibition of the interaction between the anthrax toxin and its cellular receptor by an anti-receptor monoclonal antibody.
    Li G; Qu Y; Cai C; Kong Y; Liu S; Zhang J; Zhao J; Fu L; Xu J; Chen W
    Biochem Biophys Res Commun; 2009 Aug; 385(4):591-5. PubMed ID: 19486894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring the kinetics of the pH-driven transition of the anthrax toxin prepore to the pore by biolayer interferometry and surface plasmon resonance.
    Naik S; Brock S; Akkaladevi N; Tally J; McGinn-Straub W; Zhang N; Gao P; Gogol EP; Pentelute BL; Collier RJ; Fisher MT
    Biochemistry; 2013 Sep; 52(37):6335-47. PubMed ID: 23964683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A protective antigen mutation increases the pH threshold of anthrax toxin receptor 2-mediated pore formation.
    Dennis MK; Mogridge J
    Biochemistry; 2014 Apr; 53(13):2166-71. PubMed ID: 24641616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo.
    Liu S; Crown D; Miller-Randolph S; Moayeri M; Wang H; Hu H; Morley T; Leppla SH
    Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12424-9. PubMed ID: 19617532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The receptors that mediate the direct lethality of anthrax toxin.
    Liu S; Zhang Y; Hoover B; Leppla SH
    Toxins (Basel); 2012 Dec; 5(1):1-8. PubMed ID: 23271637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A receptor-based switch that regulates anthrax toxin pore formation.
    Pilpa RM; Bayrhuber M; Marlett JM; Riek R; Young JA
    PLoS Pathog; 2011 Dec; 7(12):e1002354. PubMed ID: 22174672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation.
    Lacy DB; Wigelsworth DJ; Melnyk RA; Harrison SC; Collier RJ
    Proc Natl Acad Sci U S A; 2004 Sep; 101(36):13147-51. PubMed ID: 15326297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disulfide bonds in the ectodomain of anthrax toxin receptor 2 are required for the receptor-bound protective-antigen pore to function.
    Sun J; Collier RJ
    PLoS One; 2010 May; 5(5):e10553. PubMed ID: 20479891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterodimeric integrin complexes containing beta1-integrin promote internalization and lethality of anthrax toxin.
    Martchenko M; Jeong SY; Cohen SN
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15583-8. PubMed ID: 20713715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular dynamics simulations of complexes between wild-type and mutant anthrax protective antigen variants and a model anthrax toxin receptor.
    Stiles L; Nelson DJ
    J Biomol Struct Dyn; 2005 Apr; 22(5):503-19. PubMed ID: 15702923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-cell voltage clamp measurements of anthrax toxin pore current.
    Wolfe JT; Krantz BA; Rainey GJ; Young JA; Collier RJ
    J Biol Chem; 2005 Nov; 280(47):39417-22. PubMed ID: 16183642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular assembly of lethal factor enzyme and pre-pore heptameric protective antigen in early stage of translocation.
    Alisaraie L; Rouiller I
    J Mol Model; 2016 Jan; 22(1):7. PubMed ID: 26659402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roles of Anthrax Toxin Receptor 2 in Anthrax Toxin Membrane Insertion and Pore Formation.
    Sun J; Jacquez P
    Toxins (Basel); 2016 Jan; 8(2):34. PubMed ID: 26805886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Receptor-enhanced immunogenicity of anthrax protective antigen is primarily mediated by capillary morphogenesis Protein-2.
    Verma A; Moayeri M; Mocca CP; O'Mard D; Ma Q; Leppla SH; Burns DL
    Vaccine; 2022 Jul; 40(32):4318-4321. PubMed ID: 35710508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reengineering anthrax toxin protective antigen for improved receptor-specific protein delivery.
    Becker L; Verdurmen WPR; Plückthun A
    BMC Biol; 2020 Aug; 18(1):100. PubMed ID: 32792013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving the anti-toxin abilities of the CMG2-Fc fusion protein with the aid of computational design.
    Xi Y; Wu X; Gao L; Shao Y; Peng H; Chen H; Chen H; Hu X; Yue J
    PLoS One; 2014; 9(8):e104674. PubMed ID: 25101992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.